June 24, 2009 — On June 17, the US Food and Drug Administration (FDA) approved diclofenac potassium for oral solution (Cambia, marketed by Kowa Pharmaceuticals America, Inc, under license from Applied ...
Expanded Coverage Reaches Over 100 Million Covered Lives Nationwide COMMACK, NY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned ...
MAPLE GROVE, Minn., Nov. 28, 2017 /PRNewswire/ -- Upsher-Smith Laboratories, LLC. (Upsher-Smith) today announced the launch of KLOR-CON ® Powder (Potassium Chloride) for oral solution, 20 mEq. The ...
Camber is offering sodium sulfate, potassium sulfate and magnesium sulfate oral solution. Sodium sulfate, potassium sulfate and magnesium sulfate oral solution is an osmotic laxative indicated for ...
DUBLIN, Sept. 22, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced new real-world evidence and Phase 4 data reinforcing the value of Xywav® (calcium, magnesium, potassium, ...
Dehydration poses a serious health risk. Oral rehydration therapy offers a vital solution. Oral rehydration solutions, a mix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results